vs

Side-by-side financial comparison of ECARX Holdings Inc. (ECX) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

ECARX Holdings Inc. is the larger business by last-quarter revenue ($323.3M vs $197.9M, roughly 1.6× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs -21.4%, a 28.1% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 6.5%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-86.5M).

ECARX Holdings Inc. is a global mobility technology provider specializing in integrated smart vehicle solutions, including in-vehicle infotainment systems, advanced driver assistance technologies, and connected car cloud services. It primarily partners with automotive manufacturers across the world, with a strong operational presence in the Chinese and European markets.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

ECX vs RGEN — Head-to-Head

Bigger by revenue
ECX
ECX
1.6× larger
ECX
$323.3M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+7.1% gap
RGEN
13.6%
6.5%
ECX
Higher net margin
RGEN
RGEN
28.1% more per $
RGEN
6.7%
-21.4%
ECX
More free cash flow
RGEN
RGEN
$104.0M more FCF
RGEN
$17.6M
$-86.5M
ECX

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
ECX
ECX
RGEN
RGEN
Revenue
$323.3M
$197.9M
Net Profit
$-69.1M
$13.3M
Gross Margin
15.5%
52.5%
Operating Margin
-20.2%
9.0%
Net Margin
-21.4%
6.7%
Revenue YoY
6.5%
13.6%
Net Profit YoY
12.8%
143.9%
EPS (diluted)
$-0.20
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECX
ECX
RGEN
RGEN
Q4 25
$197.9M
Q3 25
$188.8M
Q2 25
$323.3M
$182.4M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$154.9M
Q2 24
$303.5M
$154.1M
Q1 24
$151.3M
Net Profit
ECX
ECX
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$14.9M
Q2 25
$-69.1M
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-654.0K
Q2 24
$-79.2M
$3.3M
Q1 24
$2.1M
Gross Margin
ECX
ECX
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
15.5%
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
22.6%
49.8%
Q1 24
49.5%
Operating Margin
ECX
ECX
RGEN
RGEN
Q4 25
9.0%
Q3 25
8.9%
Q2 25
-20.2%
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
-22.2%
1.0%
Q1 24
1.3%
Net Margin
ECX
ECX
RGEN
RGEN
Q4 25
6.7%
Q3 25
7.9%
Q2 25
-21.4%
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-0.4%
Q2 24
-26.1%
2.2%
Q1 24
1.4%
EPS (diluted)
ECX
ECX
RGEN
RGEN
Q4 25
$0.24
Q3 25
$0.26
Q2 25
$-0.20
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$-0.01
Q2 24
$-0.23
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECX
ECX
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$86.2M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$-293.7M
$2.1B
Total Assets
$494.9M
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECX
ECX
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$86.2M
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$108.4M
$809.1M
Q1 24
$780.6M
Total Debt
ECX
ECX
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ECX
ECX
RGEN
RGEN
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$-293.7M
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$-198.5M
$2.0B
Q1 24
$2.0B
Total Assets
ECX
ECX
RGEN
RGEN
Q4 25
$2.9B
Q3 25
$2.9B
Q2 25
$494.9M
$2.9B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$555.0M
$2.9B
Q1 24
$2.8B
Debt / Equity
ECX
ECX
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECX
ECX
RGEN
RGEN
Operating Cash FlowLast quarter
$-82.0M
$25.7M
Free Cash FlowOCF − Capex
$-86.5M
$17.6M
FCF MarginFCF / Revenue
-26.7%
8.9%
Capex IntensityCapex / Revenue
1.4%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECX
ECX
RGEN
RGEN
Q4 25
$25.7M
Q3 25
$48.1M
Q2 25
$-82.0M
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$49.3M
Q2 24
$-57.1M
$42.2M
Q1 24
$44.7M
Free Cash Flow
ECX
ECX
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$-86.5M
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$-64.9M
$37.4M
Q1 24
$36.4M
FCF Margin
ECX
ECX
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
-26.7%
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
-21.4%
24.3%
Q1 24
24.0%
Capex Intensity
ECX
ECX
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
1.4%
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
2.6%
3.1%
Q1 24
5.5%
Cash Conversion
ECX
ECX
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons